Walleye Capital
AZN icon

Walleye Capital’s AstraZeneca AZN Stock Holding History

Walleye Capital’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.64M Buy
40,300
+5,800
+17% +$1.09M 0.03% 595
2026
Q1 		$6.8M Sell
34,500
-112,350
-77% -$21.7M 0.03% 605
2025
Q4 		$27M Buy
146,850
+72,500
+98% +$12.7M 0.08% 192
2025
Q3 		$11.4M Buy
74,350
+13,100
+21% +$1.98M 0.04% 484
2025
Q2 		$8.56M Sell
61,250
-2,800
-4% -$392K 0.03% 577
2025
Q1 		$9.42M Buy
64,050
+5,250
+9% +$760K 0.04% 470
2024
Q4 		$7.71M Sell
58,800
-57,700
-50% -$8.08M 0.02% 798
2024
Q3 		$18.2M Buy
116,500
+9,500
+9% +$1.53M 0.04% 376
2024
Q2 		$16.7M Sell
107,000
-12,600
-11% -$1.9M 0.03% 445
2024
Q1 		$16.2M Sell
119,600
-6,650
-5% -$881K 0.03% 538
2023
Q4 		$17M Buy
126,250
+12,100
+11% +$1.57M 0.04% 407
2023
Q3 		$15.5M Buy
114,150
+60,050
+111% +$8.2M 0.04% 360
2023
Q2 		$7.74M Buy
54,100
+37,650
+229% +$5.54M 0.03% 513
2023
Q1 		$2.28M Buy
16,450
+8,650
+111% +$1.16M 0.03% 647
2022
Q4 		$1.06M Sell
7,800
-950
-11% -$119K 0.02% 967
2022
Q3 		$960K Buy
+8,750
New +$1.11M 0.02% 1012
2019
Q2 		– Sell
-2,450
Closed -$198K – 1726
2019
Q1 		$198K Buy
+2,450
New +$193K 0.03% 786
2018
Q3 		$293K Buy
+3,700
New +$280K 0.14% 180

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Walleye Capital's AZN Position: Q2 2026 in Review

Walleye Capital increased its AstraZeneca (AZN) stake by 500% in Q2 2026, buying an estimated $940 and bringing the position to 6 shares worth $1.14K. The position accounts for ﹤0.01% of the portfolio, ranked #4605.

Walleye Capital first reported a position in AZN in Q1 2019 and has held it in 13 quarters since. The position peaked at $40M in Q4 2025. 1,503 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Walleye Capital held 6 shares of AstraZeneca worth $1.14K as of Q2 2026.
  • Walleye Capital bought 5 AstraZeneca shares in Q2 2026, an estimated $940.
  • AstraZeneca made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4605 holding.
  • Walleye Capital first reported a position in AstraZeneca in Q1 2019 and has held it in 13 quarters since.
  • Walleye Capital's AstraZeneca position peaked at $40M in Q4 2025.
  • 1,503 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.